1. Ozkurt Z, Erol S, Kadanali A, Ertek M, Ozden K, Tasyaran MA. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists. Japanese journal of infectious diseases 2005; 58(6):338-43.
2. Ehsan H. Antibiotic resistance in developing countries: emerging threats and policy responses. Public Health Challenges 2025; 4(1):e70034.
3. Sartelli MC, Hardcastle T, Catena F, Chichom-Mefire A, Coccolini F, Dhingra S, et al. Antibiotic use in low and middle-income countries and the challenges of antimicrobial resistance in surgery. Antibiotics 2020; 9(8):497-508.
4. Yimenu DK, Emam A, Elemineh E, Atalay W. Assessment of antibiotic prescribing patterns at outpatient pharmacy using World Health Organization prescribing indicators. Journal of primary care & community health 2019; 10:2150132719886942.
5. Abelenda-Alonso G, Padullés A, Rombauts A, Gudiol C, Pujol M, Alvarez-Pouso C, et al. Antibiotic prescription during the COVID-19 pandemic: a biphasic pattern. Infection Control & Hospital Epidemiology 2020; 41(11):1371-2.
6. Sturza F, Guță ȘD, Popescu GA. Antibiotics used for COVID-19 in-patients from an infectious disease ward. Antibiotics 2023; 12(1):150-9.
7. Papiol E, Berrueta J, Ruíz-Rodríguez JC, Ferrer R, Manrique S, Claverias L, et al. Does empirical antibiotic use improve outcomes in ventilated patients with pandemic viral infection? A multicentre retrospective study. Antibiotics 2025; 14(6):594-613.
8. Stevens RW, Jensen K, O’Horo JC, Shah A. Antimicrobial prescribing practices at a tertiary-care center in patients diagnosed with COVID-19 across the continuum of care. Infection Control & Hospital Epidemiology 2021; 42(1):89-92.
9. Vaughn VM, Gandhi TN, Petty LA, Patel PK, Prescott HC, Malani AN, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study. Clinical infectious diseases 2021; 72(10):e533-41.
10. Machowska A, Landstedt K, Stålsby Lundborg C, Sharma M. Antibiotic prescribing to patients with infectious and non-infectious indications admitted to obstetrics and gynaecology departments in two tertiary care hospitals in central India. Antibiotics 2020; 9(8):464-79.
11. Kapi A. The evolving threat of antimicrobial resistance: Options for action. Indian Journal of Medical Research 2014; 139(1):182-3.
12. Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: A narrative review. Pharmaceuticals 2023; 16(11):1615-68.
13. Ferraz MP. Antimicrobial resistance: the impact from and on society according to one health approach. Societies 2024; 14(9):187-208.
14. Arteaga-Livias K, Panduro-Correa V, Maguiña JL, Osada J, Rabaan AA, Lijarza-Ushinahua K, et al. Compliance with antibiotic prophylaxis in obstetric and gynecological surgeries in two Peruvian hospitals. Antibiotics 2023; 12(5):808-17.
15. Castro-Lopes A, Correia S, Leal C, Resende I, Soares P, Azevedo A, et al. Increase of antimicrobial consumption in a tertiary care hospital during the first phase of the COVID-19 pandemic. Antibiotics 2021; 10(7):778-79.
16. Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022. EClinicalMedicine 2023; 57: 101848.
17. Petousis S, Angelou P, Almperis A, Laganà AS, Titilas G, Margioula-Siarkou C, et al. Prophylactic antibiotics before gynecologic surgery: a comprehensive review of guidelines. Journal of Personalized Medicine 2024; 14(3):327-44.
18. Naeimzadeh F, Bastani P, Shaseb E. Evaluation of antibiotic prophylaxis regimens in gynecological surgeries in a referral teaching hospital: a cross sectional study. Journal of Pharmaceutical Care 2021:190-4.
19. Magdy AM, Seksaka MA, Balata GF. Antibiotic overuse in obstetric and gynecologic procedures at Zagazig university hospitals: A prospective observational study. Pharmacia 2021; 68:883-9.